https://scholars.lib.ntu.edu.tw/handle/123456789/535249
標題: | Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: Implications for the management of immunosuppression | 作者: | HSIN-YUN SUN Alexander B.D. Huprikar S. Forrest G.N. Bruno D. Lyon G.M. Wray D. Johnson L.B. Sifri C.D. Razonable R.R. Morris M.I. Stoser V. Wagener M.M. Singh N. |
公開日期: | 2015 | 出版社: | Oxford University Press | 卷: | 60 | 期: | 1 | 起(迄)頁: | 36-44 | 來源出版物: | Clinical Infectious Diseases | 摘要: | Background. Risk factors including how changes in immunosuppression influence the occurrence of immune reconstitution syndrome (IRS) in solid organ transplant (SOT) recipients with cryptococcosis have not been fully defined. Methods. SOT recipients with cryptococcosis were identified and followed for 12 months. IRS was defined based on previously proposed criteria. Results. Of 89 SOT recipients, 13 (14%) developed IRS. Central nervous system (CNS) disease (adjusted odds ratio [AOR], 6.23; P = .03) and discontinuation of calcineurin inhibitor (AOR, 5.11; P = .02) were independently associated with IRS. Only 2.6% (1/13) of the patients without these risk factors developed IRS compared with 18.8% (6/32) with 1 risk factor, and 50% (6/12) with both risk factors (X2 for trend, P = .0001). Among patients with CNS disease, those with neuroimaging abnormalities (P = .03) were more likely to develop IRS, irrespective of serum or CSF cryptococcal antigen titers and fungemia. Graft rejection after cryptococcosis was observed in 15.4% (2/13) of the patients with IRS compared with 2.6% (2/76) of those without IRS (P = .07). Conclusions. We determined variables that pose a risk for IRS and have shown that discontinuation of calcineurin inhibitors was independently associated with 5-fold increased risk of IRS in transplant recipients with cryptococcosis. ? The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84983262159&doi=10.1093%2fcid%2fciu711&partnerID=40&md5=a0e4c2f521083593b846b98388a76abc https://scholars.lib.ntu.edu.tw/handle/123456789/535249 |
ISSN: | 1058-4838 | DOI: | 10.1093/cid/ciu711 | SDG/關鍵字: | antifungal agent; azathioprine; creatinine; cyclosporin A; fungus antigen; mycophenolate mofetil; prednisone; rapamycin; tacrolimus; calcineurin inhibitor; adult; antifungal therapy; Article; cardiac graft rejection; central nervous system disease; cerebrospinal fluid; cerebrospinal fluid flow; controlled clinical trial; controlled study; creatinine blood level; cryptococcosis; female; follow up; fungemia; graft recipient; graft rejection; heart graft; human; immune reconstitution inflammatory syndrome; immunosuppressive treatment; kidney graft; kidney graft rejection; kidney pancreas transplantation; liver graft; liver graft rejection; lung graft rejection; lung transplantation; major clinical study; male; neuroimaging; observational study; pancreas transplantation; priority journal; risk factor; serum bactericidal antibody assay; adverse effects; aged; complication; cryptococcosis; immune reconstitution inflammatory syndrome; immunosuppressive treatment; middle aged; organ transplantation; prevalence; procedures; Aged; Calcineurin Inhibitors; Cryptococcosis; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppression; Male; Middle Aged; Organ Transplantation; Prevalence; Risk Factors; Transplant Recipients |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。